换一批
换一批INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
作者：
Niklas,Grassl [1]
;
Katharina,Sahm [2]
;
Heike,Süße [3]
;
Isabel,Poschke [1]
;
Lukas,Bunse [2]
;
Theresa,Bunse [3]
;
Tamara,Boschert [4]
;
Iris,Mildenberger [1]
;
Anne-Kathleen,Rupp [5]
;
Max Philipp,Ewinger [1]
;
Lisa-Marie,Lanz [2]
;
Monika,Denk [3]
;
Ghazaleh,Tabatabai [1]
;
Michael W,Ronellenfitsch [2]
;
Ulrich,Herrlinger [1]
;
Martin,Glas [3]
;
Dietmar,Krex [6]
;
Peter,Vajkoczy [7]
;
Antje,Wick [1]
;
Inga,Harting [2]
;
Felix,Sahm [3]
;
Andreas,von Deimling [4]
;
Martin,Bendszus [4]
;
Wolfgang,Wick [4]
;
Michael,Platten [8]
作者单位：
Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKTK, DKFZ, Heidelberg, Germany.
[1]
Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany.
[2]
DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.
[3]
National Center for Tumor Diseases (NCT) Trial Center, NCT, Heidelberg, Germany.
[4]
Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[5]
Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
[6]
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
[7]
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
[8]
Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
[9]
Partner site Tübingen, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tübingen, Germany.
[10]
Department of Neurology & Neuro-Oncology, University Hospital Tübingen, Tübingen, Germany.
[11]
Center for Neuro-Oncology, Comprehensive Cancer Center, University of Tübingen, Tübingen, Germany.
[12]
Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt, Frankfurt am Main, Germany.
[13]
Division of Clinical Neurooncology, University Hospital Bonn, Bonn, Germany.
[14]
Division of Clinical Neurooncology, Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS) and West German Cancer Center, Partner Site Essen, University Hospital Essen, German Cancer Consortium, University Duisburg-Essen, Essen, Germany.
[15]
Clinic and Polyclinic for Neurosurgery, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
[16]
Department of Neurosurgery, Charité Berlin, Berlin, Germany.
[17]
Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
[18]
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
[19]
Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
[20]
Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
[21]
National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
[22]
Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKTK, DKFZ, Heidelberg, Germany. m.platten@dkfz-heidelberg.de.
[23]
Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany. m.platten@dkfz-heidelberg.de.
[24]
DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. m.platten@dkfz-heidelberg.de.
[25]
National Center for Tumor Diseases (NCT) Trial Center, NCT, Heidelberg, Germany. m.platten@dkfz-heidelberg.de.
[26]
Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center, INF 280, D69120, Heidelberg, Germany. m.platten@dkfz-heidelberg.de.
[27]
DOI
10.1186/s42466-023-00282-4
PMID
37853454
发布时间
2023-11-22
- 浏览0
Neurological research and practice
Neurological research and practice
2023年5卷1期
55页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
